| pubmed-article:2935687 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2935687 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:2935687 | lifeskim:mentions | umls-concept:C0023434 | lld:lifeskim |
| pubmed-article:2935687 | lifeskim:mentions | umls-concept:C0034789 | lld:lifeskim |
| pubmed-article:2935687 | lifeskim:mentions | umls-concept:C0205148 | lld:lifeskim |
| pubmed-article:2935687 | lifeskim:mentions | umls-concept:C0178587 | lld:lifeskim |
| pubmed-article:2935687 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:2935687 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:2935687 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:2935687 | pubmed:dateCreated | 1986-3-20 | lld:pubmed |
| pubmed-article:2935687 | pubmed:abstractText | The study consists of 6 CLL patients with leukemic blood lymphocytes lacking T-cell characteristics and with smIg on only a very small fraction of the cells detected by microscopy or FACS analysis after direct immunofluorescence (IFL) staining. Using B-cell specific monoclonal antibodies all leukemias were found to be of the B-cell type. SmIg, mainly of IgD-class and the monotypic light chain, was detected on a large number of cells in all cases when using direct IFL. No lymphocyte clone was judged to be of the pre-B-cell type or represented fully differentiated terminal B-cells. CLL cells from the individual cases probably represent intermediate B-cell maturation steps. The results lend no support to the suggestion that this subtype of CLL necessarily belongs to an early stage of differentiation just beyond the pre-B-cell level. | lld:pubmed |
| pubmed-article:2935687 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2935687 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2935687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935687 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2935687 | pubmed:issn | 0736-0118 | lld:pubmed |
| pubmed-article:2935687 | pubmed:author | pubmed-author:HolmGG | lld:pubmed |
| pubmed-article:2935687 | pubmed:author | pubmed-author:MellstedtHH | lld:pubmed |
| pubmed-article:2935687 | pubmed:author | pubmed-author:GordonJJ | lld:pubmed |
| pubmed-article:2935687 | pubmed:author | pubmed-author:BjörkholmMM | lld:pubmed |
| pubmed-article:2935687 | pubmed:author | pubmed-author:AxelssonBB | lld:pubmed |
| pubmed-article:2935687 | pubmed:author | pubmed-author:KimbyEE | lld:pubmed |
| pubmed-article:2935687 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2935687 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:2935687 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2935687 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2935687 | pubmed:pagination | 261-7 | lld:pubmed |
| pubmed-article:2935687 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:meshHeading | pubmed-meshheading:2935687-... | lld:pubmed |
| pubmed-article:2935687 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:2935687 | pubmed:articleTitle | Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg). | lld:pubmed |
| pubmed-article:2935687 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2935687 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
